Turkish Doctors Invent Groundbreaking Vaccine to Prevent Breast Cancer Progression: Clinical Trial Update

Baku, August 24, AZERTAC

Turkish doctors in the US have invented a vaccine to prevent the progression of breast cancer in the human body, reports AZERTAC according to Anadolu Agency.

The research carried out at the University of Pittsburgh Medical Center has been described as a “very important advance” by the US media.

Atilla Soran, an oncologist specializing in breast surgery who is leading the research, told Anadolu that his vaccine has drawn a lot of attention in the United States.

It is currently being tested on 10 volunteers in a clinical trial.

The trial will be expanded to 50 volunteers in the next phase, he added.

Breast cancer is one of the most common types of cancer among women, not only in the United States but throughout the world, including Türkiye.

“We believe that this vaccine will prevent the progression of breast cancer in the human body,” Soran said.

“The most important thing that the research group, in which I include myself, has achieved is that a vaccine that has been developed and tested in a laboratory for years now goes to a clinical trial,” said the Turkish professor.

The volunteers will be followed for the next five years, he said, adding that the vaccine will be approved for commercial use only after it is declared safe for use in larger clinical trials.

According to Soran, breast cancer is the second deadliest among women, after lung cancer.

About 360,000 women in the US are expected to be diagnosed with breast cancer by 2023, he said, adding that only 16% of them will receive an early diagnosis.

“If the vaccine enters into force in this same phase, we believe that we will be able to prevent the disease from progressing in the body of at least a large part of those 360,000 women,” he stressed.

A total of 24,000 women were diagnosed with the disease in Türkiye in 2020, Soran said, criticizing that the screening program has not reached the desired level.

It’s vital that women over the age of 40 get a mammogram annually, she advised.

“If you get about 1,000 mammograms, if you’ve screened 1,000 women, you’ve caught one or two cases of very early-stage breast cancer,” he added.

“One in a thousand, in fact, when multiplied by millions, it makes a very large number,” said the professor, who also suggested that with early diagnosis, as with all diseases, expensive treatments such as radiotherapy can be avoided. , chemotherapy, immunotherapy and surgery.

He noted that clinical trials for the vaccine are progressing slowly because breast cancer does not pose an acute risk like the COVID-19 pandemic.

She stressed that research on breast cancer began in the 1980s and 1990s.

“Nearly 10% of breast cancer cases are caused by genes, and women with those genes also have an 80% chance of being diagnosed with breast or ovarian cancer in their lifetime,” he said.

Going for frequent checkups is crucial for all women, she stressed.

Walking for half an hour every day also “greatly” reduces the risk of breast cancer, he said, adding that women should also be careful about their body length-to-weight ratio.

Those who give birth before age 35 and those who don’t drink alcohol are less likely to be diagnosed with breast cancer, he said.

Breast cancer would no longer be a deadly disease if diagnosed early, he said.

After being invited to the United States in 1997 to work as an expert, Soran in 2004 became the first person to obtain a professorship in the Department of Mammoplasty at the University of Pittsburgh.

In 2007, she called her research shedding new light on advanced breast cancer the “Turkish Study.”

It is still recognized by the same name throughout the world.

The Turkish doctor continues to maintain strong ties with Türkiye.

© When using material on this site, note the hyperlink.

2023-08-24 07:30:00
#Turkish #doctors #develop #vaccine #prevent #breast #cancer